Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,433,176
  • Shares Outstanding, K 227,074
  • Annual Sales, $ 2,252 M
  • Annual Income, $ 512,600 K
  • 60-Month Beta 0.42
  • Price/Sales 5.09
  • Price/Cash Flow 13.36
  • Price/Book 3.44
Trade QGEN with:

Options Overview Details

View History
  • Implied Volatility 32.28% ( +1.69%)
  • Historical Volatility 29.72%
  • IV Percentile 10%
  • IV Rank 16.10%
  • IV High 56.01% on 10/10/22
  • IV Low 27.72% on 07/19/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 29
  • Volume Avg (30-Day) 496
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 33,263
  • Open Int (30-Day) 34,591

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.47
  • Number of Estimates 5
  • High Estimate 0.48
  • Low Estimate 0.45
  • Prior Year 0.74
  • Growth Rate Est. (year over year) -36.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.78 +17.74%
on 11/07/22
50.50 -2.59%
on 12/02/22
+6.52 (+15.28%)
since 11/04/22
3-Month
40.38 +21.82%
on 10/10/22
50.50 -2.59%
on 12/02/22
+3.82 (+8.42%)
since 09/02/22
52-Week
40.38 +21.82%
on 10/10/22
56.18 -12.44%
on 12/28/21
-5.01 (-9.24%)
since 12/03/21

Most Recent Stories

More News
QIAGEN's (QGEN) New Monkeypox Test to Aid Faster Identification

QIAGEN's (QGEN) latest multiplex test is expected to strengthen its portfolio and boost its fight against the global monkeypox outbreak.

MCK : 381.64 (-1.35%)
QGEN : 49.09 (-2.50%)
AMN : 119.14 (-3.83%)
SWAV : 240.07 (-3.93%)
3 Reasons to Retain QIAGEN (QGEN) Stock in Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on the back of a series of product launches.

MCK : 381.64 (-1.35%)
QGEN : 49.09 (-2.50%)
AMN : 119.14 (-3.83%)
SWAV : 240.07 (-3.93%)
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the monkeypox (MPXV) test for its NeuMoDx automated PCR platform to strengthen surveillance and research into the...

QGEN : 49.09 (-2.50%)
QIAGEN's (QGEN) Q3 Earnings Top Estimates, 2022 View Up

The ongoing double-digit sales growth in the non-COVID product portfolio, a high level of profitability and strong cash flow are the major upsides for QIAGEN (QGEN).

QGEN : 49.09 (-2.50%)
MMSI : 70.86 (-2.98%)
AMN : 119.14 (-3.83%)
MEDP : 203.50 (-2.63%)
Qiagen (QGEN) Tops Q3 Earnings and Revenue Estimates

Qiagen (QGEN) delivered earnings and revenue surprises of 17.78% and 4.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

QGEN : 49.09 (-2.50%)
ARDS : 1.0000 (+5.26%)
Qiagen: Q3 Earnings Snapshot

Qiagen: Q3 Earnings Snapshot

QGEN : 49.09 (-2.50%)
QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the third quarter of 2022 and first nine months of 2022, and increased the outlook for full-year 2022.

QGEN : 49.09 (-2.50%)
Earnings Preview: Qiagen (QGEN) Q3 Earnings Expected to Decline

Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

QGEN : 49.09 (-2.50%)
NVAX : 17.10 (+3.51%)
PacBio's (PACB) Latest Offering to Enhance Genome Sequencing

PacBio's (PACB) latest sequencing panels are expected to simplify the study of the difficult-to-sequence or accurately map genomes, thereby aiding researchers.

TMO : 556.42 (-1.17%)
ILMN : 215.16 (-1.65%)
QGEN : 49.09 (-2.50%)
PACB : 10.05 (-5.72%)
PacBio's (PACB) Latest Offering to Enhance Disease Discoveries

PacBio's (PACB) latest sequencing kit is expected to help generate insights into how single-cell research can power new disease discoveries and the identification of therapeutic targets across many categories....

TMO : 556.42 (-1.17%)
QGEN : 49.09 (-2.50%)
PACB : 10.05 (-5.72%)
TXG : 36.03 (-7.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed...

See More

Key Turning Points

3rd Resistance Point 51.43
2nd Resistance Point 50.96
1st Resistance Point 50.66
Last Price 49.09
1st Support Level 49.89
2nd Support Level 49.42
3rd Support Level 49.12

See More

52-Week High 56.18
Fibonacci 61.8% 50.14
Last Price 49.09
Fibonacci 50% 48.28
Fibonacci 38.2% 46.42
52-Week Low 40.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar